Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis
Clinical trial NCT02888379 · COMPLETED
Trial details
- NCT number
- NCT02888379
- Sponsor
- Topivert Pharma Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-01
- Primary completion
- 2017-06-28
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.